2012年毕业于中国药科大学药物化学专业，获得理学博士学位，2013年进入中国药科大学理学院有机化学教研室工作至今，现为副教授。2016年3月至2017年3月在美国University of Minnesota著名药物化学家Gunda I. Georg课题组做国家公派访问学者。

研究方向为小分子靶向抗肿瘤药物的设计与合成，以及利用CADD和AI技术发现针对肿瘤、炎症等疾病的新分子实体。

Wang ZJ, Cai JH, Ren JW, Chen Y, Wu YL, Cheng J, Jia K, Huang F, Cheng ZT, Sheng TC, Song SY, Heng H, Zhu YF, Tang WF, Li HM*, Lu T*, Chen YD*, Lu S*. Discovery of a Potent FLT3 Inhibitor (LT-850-166) with Capacity of Overcoming a Variety of FLT3 Mutations. [J]. J. Med. Chem. 2021, 64 (19), 14664-14701. Wang ZJ, Cai JH, Cheng J, Yang WQZ, Zhu YF, Li HM, Lu T*, Chen YD*, Lu S*. FLT3 inhibitors in acute myeloid leukemia: challenges and recent developments in overcoming resistance [J]. J. Med. Chem. 2021, 64 (6), 2878-2900. Cui QJ#, Lu S#, Ni BW, Zeng X, Tan Y, Chen YD*, Zhao HP*. Improved prediction of aqueous solubility of novel compounds by going deeper with deep learning [J]. Front. Oncol. 2020, 10, 121. Bao JY #, Liu HC #, Zhi YL, Yang WQZ, Zhang JW, Lu T, Wang Y *, Lu S *. Discovery of benzo[d]oxazole derivatives as the potent type-I FLT3-ITD inhibitors [J]. Bioorg. Chem. 2020, 94, 103248. Heng H#, Wang ZJ#, Li HM#, Huang YT, Lan QY, Guo XX, Zhang L, Zhi YL, Cai JH, Qin TR, Xiang L, Wang SX, Chen YD*, Lu T, Lu S*. Combining structure- and property-based optimization to identify selective FLT3-ITD inhibitors with good antitumor efficacy in AML cell inoculated mouse xenograft model [J]. Eur. J. Med. Chem. 2019, 176, 248-267. Ran T#, Li WJ#, Peng BL, Xie BL, Lu T, Lu S*, Liu W*. Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1 [J]. J. Chem. Inf. Model. 2019, 59(1), 522-534. Heng H#, Zhi YL#, Yuan HL#, Wang ZJ, Li HM, Wang SX, Tian JY, Liu HC, Chen YD, Lu T*, Ran T*, Lu S*. Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation [J]. Eur. J. Med. Chem. 2019, 163, 195-206. Zhi YL, Li BQ, Yao C, Li HM, Chen PZ, Bao JY, Qin TR, Wang Y, Lu T*, Lu S*. Discovery of the selective and efficacious inhibitors of FLT3 mutations [J]. Eur. J. Med. Chem. 2018, 155, 303-315.